B. Metzler seel. Sohn & Co. Holding AG Acquires Shares of 5,410 Axon Enterprise, Inc. (NASDAQ:AXON)

B. Metzler seel. Sohn & Co. Holding AG bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the third quarter, Holdings Channel reports. The firm bought 5,410 shares of the biotechnology company’s stock, valued at approximately $2,162,000.

Other hedge funds have also recently made changes to their positions in the company. Blue Trust Inc. increased its holdings in Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the last quarter. Quent Capital LLC increased its stake in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares in the last quarter. Asset Dedication LLC bought a new stake in shares of Axon Enterprise in the second quarter valued at approximately $47,000. Planning Capital Management Corp raised its position in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the period. Finally, Friedenthal Financial purchased a new stake in shares of Axon Enterprise during the 3rd quarter valued at approximately $51,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Up 3.6 %

AXON stock opened at $632.04 on Friday. The company’s 50 day moving average is $458.43 and its 200 day moving average is $365.54. The stock has a market cap of $48.19 billion, a price-to-earnings ratio of 163.32, a price-to-earnings-growth ratio of 18.26 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $224.28 and a 1-year high of $640.51.

Insiders Place Their Bets

In other news, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 330,256 shares of company stock valued at $131,338,820 in the last quarter. Corporate insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

AXON has been the subject of a number of recent research reports. Barclays lifted their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. The Goldman Sachs Group increased their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Robert W. Baird lifted their target price on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.